|
(V978) |
Drug-screening from short QT syndrome type 1 using human-induced pluripotent stem cell-derived cardiomyocytes |
| |
|
Z. Zhao, X. Li, H. Lan, I. El-Battrawy, Q. Xu, M. Huang, R. Zhong, Z. Liao, S. Lang, W.-H. Zimmermann, L. Cyganek, T. Wieland, M. Borggrefe, K. Odening, X. Zhou, I. Akin (Mannheim, Göttingen, Freiburg im Breisgau) |
|
|
Diskussion |
|
(V979) |
Ivabradine is associated with a positive inotropic effect in in-vitro experiment |
| |
|
R. Chaban, K. Buschmann, A. Beiras-Fernandez, C.-F. Vahl (Mainz) |
|
|
Diskussion |
|
(V980) |
Comprehensive analysis of genome-wide significant genetic variants influencing ECG markers |
| |
|
R. Freudling, M. Müller-Nurasyid, T. Meitinger, A. Peters, K. Strauch, M. Waldenberger, S. Kääb, M. F. Sinner (Neuherberg, München) |
|
|
Diskussion |
|
(V981) |
Pharmacological inhibition of atrial TASK-1 channels facilitates acute cardioversion of atrial fibrillation in a porcine large animal model |
| |
|
F. Wiedmann, C. Beyersdorf, A. Ratte, M. A. Waibel, M. Kraft, H. A. Katus, C. Schmidt (Heidelberg) |
|
|
Diskussion |
|
(V982) |
Modeling Brugada syndrome with CACNb2 mutation using hiPSC |
| |
|
I. El-Battrawy, T. Schimanski, H. Lan, L. Cyganek, Z. Zhao, X. Li, S. Lang, S. Diecke, W.-H. Zimmermann, J. Utikal, T. Wieland, M. Borggrefe, X. Zhou, I. Akin, für die Studiengruppe: UMM-Akin (Mannheim, Göttingen, Berlin) |
|
|
Diskussion |
|
(V983) |
Propofol reduces atrial fibrillation in a whole-heart model |
| |
|
C. Ellermann, H. Könemann, S. Kochhäuser, D. Dechering, J. Köbe, K. Wasmer, L. Eckardt, G. Frommeyer (Münster) |
|
|
Diskussion |